$RPID 4 SEC Filings

Filed On	Filing
24 Jul 2026	Form 4: Kollender Richard S, Director Received 3,508 shares by exercise or conversion ($2.63K)
24 Jul 2026	Form 4: Spignesi Robert G. Jr., Director Received 1,402 shares by exercise or conversion ($1.05K)
02 Jun 2026	Form 4: Lowenstein Inese, Director Received 12,787 shares as a grant or award ($25K) · Granted 12,787 Series A Warrant (right to buy) · Granted 12,787 Series B Warrant (right to buy)
02 Jun 2026	Form 4: Pei Melinda Litherland, Director Received 12,787 shares as a grant or award ($25K) · Granted 12,787 Series A Warrant (right to buy) · Granted 12,787 Series B Warrant (right to buy)
02 Jun 2026	Form 4: Malloy Kirk, Director Received 12,787 shares as a grant or award ($25K) · Granted 12,787 Series A Warrant (right to buy) · Granted 12,787 Series B Warrant (right to buy)
02 Jun 2026	Form 4: Wirtjes Sean M, CHIEF FINANCIAL OFFICER Received 12,787 shares as a grant or award ($25K) · Granted 12,787 Series A Warrant (right to buy) · Granted 12,787 Series B Warrant (right to buy)
02 Jun 2026	Form 4: Spignesi Robert G. Jr., Director Received 12,787 shares as a grant or award ($25K) · Granted 12,787 Series A Warrant (right to buy) · Granted 12,787 Series B Warrant (right to buy)
26 May 2026	Form 4: Malloy Kirk, Director Received 19,300 shares as a grant or award · Granted 38,700 Stock Option (Right to Buy)
26 May 2026	Form 4: Lowenstein Inese, Director Received 19,300 shares as a grant or award · Granted 38,700 Stock Option (Right to Buy)
26 May 2026	Form 4: Pei Melinda Litherland, Director Received 19,300 shares as a grant or award · Granted 38,700 Stock Option (Right to Buy)
26 May 2026	Form 4: Kollender Richard S, Director Received 19,300 shares as a grant or award · Granted 38,700 Stock Option (Right to Buy)
26 May 2026	Form 4: Bika Dafni, Director Received 19,300 shares as a grant or award · Granted 38,700 Stock Option (Right to Buy)
22 May 2026	Form 4: Bain Capital Life Sciences Investors, Llc, 10% owner and 3 others Acquired 1,463,000 Pre-Funded Warrant (right to buy) (Open Market Purchase) · Acquired 1,463,000 Series A Warrant (right to buy) (Open Market Purchase) · Acquired 1,463,000 Series B Warrant (right to buy) (Open Market Purchase)
12 Mar 2026	Form 4: Wilson John J. Addington, CHIEF OPERATING OFFICER Sold 9,603 shares ($41.5K)
12 Mar 2026	Form 4: Wirtjes Sean M, CHIEF FINANCIAL OFFICER Sold 7,480 shares ($32.3K)
12 Mar 2026	Form 4: Spignesi Robert G. Jr., Director Sold 17,922 shares ($73.7K)
02 Mar 2026	Form 4: Ricciardi Natale S, Director Received 842 shares by exercise or conversion ($632)
20 Feb 2026	Form 4: Wilson John J. Addington, CHIEF OPERATING OFFICER Sold 5,403 shares ($21.2K)
20 Feb 2026	Form 4: Wirtjes Sean M, CHIEF FINANCIAL OFFICER Sold 17,254 shares ($67.7K)
20 Feb 2026	Form 4: Spignesi Robert G. Jr., Director Sold 38,327 shares ($149K)

Comments